Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use JOENJA safely and effectively. See full prescribing information for JOENJA. JOENJA® (leniolisib) tablets, for oral useInitial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
JOENJA is indicated for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older.
- generic_name
- leniolisib
- product_names
- Leniolisib
- ndc
- 71274-170, 71274-170-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en